Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05776914 · ClinicalTrials.gov registry record · Phase 2

Fecal Microbiota Transplantation for IBS

A Phase 2 study of Irritable Bowel Syndrome and Diarrhea, sponsored by Madhusudan (Madhu) Grover, MBBS.

Recruiting
Registry status
Phase 2
Development phase
43
Enrollment target
1
Study location

NCT05776914 is a Phase 2 study of Irritable Bowel Syndrome and Diarrhea that is actively recruiting participants, run by Madhusudan (Madhu) Grover, MBBS. The registered enrollment target is 43 participants, below the 143-participant average among 47 other Irritable Bowel Syndrome trials with a reported enrollment target (70% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05776914, a Phase 2 study of Irritable Bowel Syndrome and Diarrhea, is actively recruiting participants, sponsored by Madhusudan (Madhu) Grover, MBBS.

RECRUITING
Registry status
Phase 2
Development phase
43 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to learn the efficacy and safety of fecal microbiota transplantation (FMT) using stool from a donor with low proteolytic activity and containing the bacteria Alistipes putredinis in patients with irritable bowel syndrome (IBS) and high proteolytic activity. Proteolytic activity is the breakdown of proteins into smaller polypeptides or amino acids.

Conditions Studied

Irritable Bowel Syndrome Diarrhea

Interventions

  • BIOLOGICAL Donor Fecal Microbiota Transplantation
  • BIOLOGICAL Autologous Fecal Microbiota Transplantation

Study Locations (1)

Minnesota

  • Mayo Clinic in Minnesota - Rochester

Trial Details

FieldValue
Enrollment Target 43 participants
Start Date 2024-04-15
Est. Completion 2026-12
Phase Phase 2

Sponsor

Madhusudan (Madhu) Grover, MBBS

1 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05776914

The ClinicalTrials.gov registry entry for NCT05776914 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 43 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 143-participant average among 47 other Irritable Bowel Syndrome trials with a reported enrollment target (70% lower). The listed sponsor is Madhusudan (Madhu) Grover, MBBS, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Irritable Bowel Syndrome appearing as the primary indexed condition, and to 2 interventions - of which Donor Fecal Microbiota Transplantation is the first listed.

NCT05776914 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.

Frequently Asked Questions

What is clinical trial NCT05776914 about?

NCT05776914 is a clinical study titled "Fecal Microbiota Transplantation for IBS". The purpose of this study is to learn the efficacy and safety of fecal microbiota transplantation (FMT) using stool from a donor with low proteolytic activity and containing the bacteria Alistipes putredinis in patients with irritable bowel syndrome (IBS) and high proteolytic activity. Proteolytic a...

What is the current status of trial NCT05776914?

This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 43 participants. The study started on 2024-04-15. Estimated completion is 2026-12.

What conditions does trial NCT05776914 study?

This clinical trial studies the following conditions: Irritable Bowel Syndrome, Diarrhea.

What interventions are being tested in trial NCT05776914?

The interventions under investigation include: Donor Fecal Microbiota Transplantation (BIOLOGICAL), Autologous Fecal Microbiota Transplantation (BIOLOGICAL).

Who is sponsoring clinical trial NCT05776914?

This trial is sponsored by Madhusudan (Madhu) Grover, MBBS, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05776914 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Irritable Bowel Syndrome

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Irritable Bowel Syndrome

All registered trials for this condition

Diarrhea

All registered trials for this condition

Minnesota

All trials with a study site in Minnesota

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.